Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Byetta

Subscribe to Byetta RSS Feed

1995 – Pancreatitis found associated with pancreatic cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Author P. Bansal from the Division of Gastroenterology at the Department of Veterans Affairs Medical Center in Milwaukee, Wisconsin, conducted a study called “Pancreatitis is a Risk Factor For Pancreatic Cancer”, where the main goal was to determine if pancreatitis is a risk factor for pancreatic cancer.  Information for this study was obtained from the… Continue Reading

2004 – Research Connects Pancreatitis and Pancreatic Cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Recent studies have shown that there is a positive correlation between pancreatic inflammation and an increased risk of pancreatic cancer.  While acute pancreatitis that appears suddenly and may last for only a few days may not put an individual at a higher risk for cancer, chronic pancreatitis may last for several years and is associated… Continue Reading

2011 – Pancreatitis, Pancreatic, and Thyroid Cancer Associated with GLP-1 Therapy Drugs

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

In 2011, M. Elashoff, from the Larry L. Hillblom Islet Research Center at David Geffen School of Medicine and Department of Biomathematics at University of California, Los Angeles, published a study titled “Pancreatitis, Pancreatic, and Thyroid Cancer with Glucagon like Peptide-1-based Therapies”, wherein concerns regarding risk for pancreatitis and pancreatic and thyroid cancers are explored…. Continue Reading

2013 – Study links Byetta, Victoza, Januvia to pancreatitis, pancreatic cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Studies have shown that pancreatitis is associated with the use of exenatide (Byetta, Bydureon), liraglutide (Victoza), and sitagliptin (Januvia, Janumet, Janumet XR, Juvisync) and other glucagon like peptide 1 (GLP-1) receptor agonists.  The pancreatitis associated with these therapies and medications may increase the risks for pancreatic cancer.  Experiments done on mice and rats have shown… Continue Reading

GLP-1 therapy drugs lead to pancreatitis, pancreatitis dramatically increases risk for cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Author S. Raimondi from the European Institute of Oncology in Milan, Italy, wrote an article titled “Pancreatic Cancer in Chronic Pancreatitis; Aetiology, Incidence, and Early Detection”.  Chronic pancreatitis, acute pancreatitis, and pancreatic cancer are primarily responsible for most of the negative effects of exocrine pancreatic disease.  The pancreas is a flat gland found in the… Continue Reading

Victoza, Byetta, Januvia and others can lead to pancreatic cancer

Posted in Byetta, GLP-1 Diabetes Drugs, Januvia, Victoza

Some studies and anecdotal reports have shown that pancreatitis may cause an individual to develop, or be at a higher risk to develop pancreatic cancer.  Pancreatitis is defined as inflammation in the pancreas.  The pancreas produces enzymes that help with digestion as well as produce hormones that regulate the way your body processes sugar.  Pancreatitis… Continue Reading

News about link between Byetta and acute renal failure

Posted in Byetta, Safety Alerts

Just got this in my email from the FDA: Byetta (exenatide) – Renal Failure Audience: Endocrine and nephrology healthcare professionals FDA notified healthcare professionals of revisions to the prescribing information for Byetta (exenatide) to include information on post-marketing reports of altered kidney function, including acute renal failure and insufficiency. Byetta, an incretin-mimetic, is approved as… Continue Reading